Skip to main content

Table 2 CGAC and Advanced CGAC Cell Counts in Malignant and Benign Participant Samples

From: The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules

n (%)

Total Participant Samples

(n = 151)

Malignant Participant Samples

(n = 112)

Benign Participant Samples

(n = 39)

P value

(Malignant vs. Benign Participant Samples)

Advanced CGAC

48 (31.8)

44 (39.3)

4 (10.3)

0.001*

  1. Abbreviations: CGAC, circulating genetically abnormal cell
  2. * Chi-Square Test